As of Mar 24
| -0.16 / -0.66%|
The 5 analysts offering 12-month price forecasts for LeMaitre Vascular Inc have a median target of 26.00, with a high estimate of 27.00 and a low estimate of 25.00. The median estimate represents a +8.56% increase from the last price of 23.95.
The current consensus among 6 polled investment analysts is to Buy stock in LeMaitre Vascular Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.